Equigerminal is a brand dedicated to keeping horses healthy and protected from diseases. Isabel and Alexandre, with their deep passion for horses, have spent the last 25 years identifying diseases, uncovering new threats, and developing innovative equine diagnostics and therapies. As the sole shareholders of Equigerminal, they reinvest all the company's profits in research and development or efforts to improve the lives of animals.

One of Equigerminal's commitments is the conservation of the ancient Portuguese breed of endangered native ponies, the Garranos. In addition, they use cutting-edge biotechnology to improve horse health and make their diagnosis tools available to all horses. Isabel, the CEO and CSO of Equigerminal, has a veterinary and research background, focusing on equine virology and immunology.

Alexandre, the COO and CFO, is an agricultural engineer passionate about bringing cutting-edge innovations to horses. With products and services such as DNA testing, pathogen testing, blood testing, SARS-CoV-2 testing, and allergy testing, Equigerminal aims to provide comprehensive solutions for horse health. Their dedication to the well-being of horses and their expertise make them a trusted brand in the equestrian community